• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Jim Cramer

Jim Cramer: Where Can You Still Get Some Growth and a Big Yield?

Right now, AbbVie is the best way to capitalize on the moment and on the future.
By JIM CRAMER
Oct 16, 2019 | 02:28 PM EDT
Stocks quotes in this article: M, BP, SLB, KSS, AMZN, AEP, ED, D, ABBV, AGN

What happened to the power of dividends to protect stocks from falling too precipitously? How can the stock of Macy's (M) yield 9% even as the company is profitable and has an improved balance sheet? How is it possible that BP (BP) can yield 6% even as the company can increase the dividend and has a much better balance sheet than before? Let's throw in Schlumberger (SLB) , the pride of the oil patch, a company I have known for almost 40 years when I thought about getting a job there until I realized that I simply wasn't smart enough to get the job. How can that best in class company yield 6%?

And because as Action Alerts PLUS club members know my self-excoriation knows few bounds, what is the stock of Kohl's (KSS) doing yielding 5.2% even as it has a tie-up with Amazon (AMZN) to return goods and it offers some real bargains on national brands? The answer? None of these companies is perceived to have any growth whatsoever and some, like Schlumberger, are expected to miss numbers. I don't think it is a stretch that Kohl's will either. It did it before Michelle Gass seemed to indicate things were doing well. It could certainly do it again.

Contrast those with companies like American Electric Power (AEP) or Con Ed (ED) . Sure the growth is not rampant, but it isn't episodic, its consistent. Why not buy a Dominion (D) with a 4.5% yield. It's going to grow and grow just fine, now that the SCANA deal's closed. Nothing like a merger among utilities to give you multiyear growth.

But woe be the master limited partnerships in oil and gas. Some of these yield 7, 8, 9, 10, even 11 or 12 percent and it's offered no protection because there is no growth.

My favorite right now is AbbVie (ABBV) which is merging with Allergan (AGN) to form a company that is far less beholden to their master drug, Humira, which has dominated the company's earnings stream for ages and is already losing exclusivity in Europe to biosimilars and only has a couple of years before its patents expire here. The drug, used for Crohn's disease, psoriasis and rheumatoid arthritis, should do $21 billion next year.

But, again, because its growth is supposed to run out then, nobody cared about its 6%-7% yield. Then the company decided to buy Allergan in a cash and stock deal worth $63 billion. As the deal draws closer to conclusion investors are recognizing that AbbVie will now have some growth, whether it be from botox or from its eye care franchise or from its new pill for acute sufferers of migraine. As the spokesman for the American Migraine Foundation I can tell you that this pill will be a blockbuster. Those of us who suffer from terrible migraines know there is nothing that you can just pop into your mouth to quell the pain. I expect to get a vicious migraine tomorrow if it rains as much as the weather people say. The pill is on the verge of being approved and should boost next year's earnings.

In a moment where the market's slaughtering high growth stocks, buying stocks with decent dividends AND growth is a winning formula. I think it's going to stay that way and AbbVie is the best way to capitalize on the moment and on the future.

(BP, Schlumberger, Kohl's, Amazon and AbbVie are holdings in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, is long BP, SLB, KSS, AMZN, ABBV. 

TAGS: Dividends | Markets | Stocks | Trading | Jim Cramer

More from Jim Cramer

Jim Cramer: This GameStop Nonsense Has Gotten Out of Hand

Jim Cramer
Feb 26, 2021 7:11 AM EST

It has become the market equivalent of the storming of the Capitol, and the viciousness must stop.

Jim Cramer: The Bond Market Vigilantes Strike

Jim Cramer
Feb 25, 2021 1:41 PM EST

What does that mean for stocks? Consider Nvidia.

Jim Cramer: How Do You Pull Off What GameStop Buyers Did?

Jim Cramer
Feb 25, 2021 6:12 AM EST

Here's my theory on how this was done.

Jim Cramer: Don't Miss This Train

Jim Cramer
Feb 22, 2021 2:40 PM EST

We're headed to Boom Town, so let me show you how to line up your ticket -- and the best picks for the great reopening.

Jim Cramer: Toast, the Next Big Thing? I Question its Valuation

Jim Cramer
Feb 22, 2021 6:19 AM EST

Maybe it will be viewed as the ultimate 'opening' story because restaurants might soon come back.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:51 AM EST REAL MONEY

    Watch Bob Lang and Doug Kass Discuss Short-Selling!

    Bob Lang and Doug Kass with an engaging and educat...
  • 11:32 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    Navigating a Market Correction
  • 11:29 AM EST GARY BERMAN

    Where Does the Nasdaq Go From Here?

    Where does the Nasdaq Composite (CCMP) index go fr...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login